Dexamethasone for Reduction of Post Thoracotomy Pain Syndrome
NCT ID: NCT02112864
Last Updated: 2023-03-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2014-05-31
2025-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dexmedetomidine for the Control of Post-Operative Pain in Thoracotomy Patients
NCT00345384
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy
NCT05120076
DEXAMETHASONE for Non-urgent Thoracic Surgery
NCT05136781
Role of Dexamethasone in Multimodal Analgesia for Postoperative Pain in Thoracic Surgery
NCT04325984
Effects of Perioperative Intravenous Dexamethasone on Pain in Out Patient Knee Surgery
NCT01149616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexamethasone 10 mg
Dexamethasone 10 mg will be given as a single-dose, pre incision, intravenously
Dexamethasone
10 mg (2.5 ml)
normal saline
Patients in this group will receive 2.5 mL of normal saline intravenously, pre-incision
Normal Saline
2.5 mL normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexamethasone
10 mg (2.5 ml)
Normal Saline
2.5 mL normal saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-III
* age 18-75 yo
Exclusion Criteria
* patient refusal
* patients already taking cortisone or dexamethasone
* patients on chronic opioid medication
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maisonneuve-Rosemont Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Veronique Brulotte
M.D., M.Sc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Veronique Brulotte, MD, Msc
Role: PRINCIPAL_INVESTIGATOR
Maisonneuve-Rosemont Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maisonneuve-Rosemont Hospital
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
dexaPTPS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.